NCT00006034View on ClinicalTrials.gov

Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 1998

Study Completion Date

March 31, 2004

Conditions
Bladder Cancer
Interventions
BIOLOGICAL

keyhole limpet hemocyanin

Given intradermally and IV

DRUG

doxorubicin hydrochloride

Given IV

Trial Locations (1)

21701

Intracel Resources, LLC, Frederick

Sponsors

Lead Sponsor

Intracel
All Listed Sponsors
lead

Intracel

INDUSTRY